Page last updated: 2024-08-23

staurosporine and 4,5,6,7-tetrabromo-2-azabenzimidazole

staurosporine has been researched along with 4,5,6,7-tetrabromo-2-azabenzimidazole in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bain, J; Battistutta, R; de Moliner, E; Elliott, M; Fabbro, D; Furet, P; Meggio, F; Pagano, MA; Pinna, LA; Ruzzene, M; Sarno, S; Schoepfer, J; Zanotti, G1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M1
Davies, SP; Donella-Deana, A; Meggio, F; Pinna, LA; Reddy, H; Ruzzene, M; Sarno, S; Shugar, D1
Duncan, JS; Kerman, K; Kraatz, HB; Litchfield, DW; Song, H1

Reviews

1 review(s) available for staurosporine and 4,5,6,7-tetrabromo-2-azabenzimidazole

ArticleYear
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
    Journal of medicinal chemistry, 2018, 11-21, Volume: 61, Issue:22

    Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases

2018

Other Studies

4 other study(ies) available for staurosporine and 4,5,6,7-tetrabromo-2-azabenzimidazole

ArticleYear
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
    The Biochemical journal, 2003, Sep-15, Volume: 374, Issue:Pt 3

    Topics: Acetates; Animals; Casein Kinase II; Cell Line; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Jurkat Cells; Molecular Structure; Plant Proteins; Protein Serine-Threonine Kinases; Protein Structure, Quaternary; Quinazolines; Rats; Zea mays

2003
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2').
    FEBS letters, 2001, May-04, Volume: 496, Issue:1

    Topics: Adenosine Triphosphate; Amino Acid Substitution; Binding Sites; Binding, Competitive; Casein Kinase II; Emodin; Enzyme Inhibitors; Humans; Jurkat Cells; Protein Kinases; Protein Serine-Threonine Kinases; Staurosporine; Substrate Specificity; Triazoles

2001
Peptide biosensors for the electrochemical measurement of protein kinase activity.
    Analytical chemistry, 2008, Dec-15, Volume: 80, Issue:24

    Topics: Adenosine Triphosphate; Benzimidazoles; Biosensing Techniques; Bone Neoplasms; Casein Kinase II; Catalysis; Electrochemistry; Ferrous Compounds; fms-Like Tyrosine Kinase 3; Humans; Kinetics; Metallocenes; Mutation; Osteosarcoma; Oxidation-Reduction; Peptide Fragments; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Receptor, ErbB-2; Staurosporine; Triazoles; Tumor Cells, Cultured

2008